Global Medical Foods For Inborn Errors Of Metabolism Market 2024 - Exploring Growth Factors, Segmenting Applications, Conducting Regional Analysis, Profiling Key Players, and Forecasting Trends Until 2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Medical Foods For Inborn Errors Of Metabolism Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The medical foods for inborn errors of metabolism market size has grown rapidly in recent years. It will grow from $2.72 billion in 2023 to $3.08 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to global health initiatives, increased recognition of nutritional therapies, precision medicine approaches, increasing incidence of metabolic disorders, personalized digital nutrition platforms.

The medical foods for inborn errors of metabolism market size is expected to see rapid growth in the next few years. It will grow to $4.83 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to telehealth integration, rising demand for clean label products, expanded newborn screening programs, patient-centric care models, plant-based and sustainable formulations. Major trends in the forecast period include technological advancements in genetic testing, advancements in food processing technologies, innovations in ingredient technology, technological advancements in food formulation.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12161&type=smp

Market Segmentation:
The medical foods for inborn errors of metabolism market covered in this report is segmented -
1) By Product: Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, Other Products
2) By Diseases: Phenylket*onuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Other Diseases
3) By Age Group: Infants, Weaning, Adolescent, Adults
4) By Forms: Powder, Liquids, Gels, Other Forms
5) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Other Distribution Channels

Major Driver - Rise In Genetic Disorders Drives Growth Of Medical Foods For Inborn Errors In Metabolism Market
The rise in genetic (inherited) disorders is expected to propel the growth of medical foods for inborn errors in the metabolism market going forward. Genetic (inherited) disorders refer to a disease that is entirely or partially brought on by a deviation from the typical DNA sequence. Medical foods are essential for infants with metabolic abnormalities to deliver specialized nutrition created to address the unique metabolic requirements of people with these illnesses, thereby assisting in the prevention of nutritional deficits and metabolic needs for promoting their growth and well-being. For instance, in May 2021, according to Medline Plus, a US-based online information service produced by the United States National Library of Medicine, the incidence of a gene variant each year in the United States diagnoses 1 in 200,000 individuals with syndrome A. Around the world, 15,000 patients with syndrome B have been diagnosed. Therefore, the rise in genetic (inherited) disorders is driving the growth of medical foods for inborn errors of metabolism market.

Competitive Landscape:
Major companies operating in the medical foods for inborn errors of metabolism market report are BASF SE, Abbott Laboratories Inc, Danone SA, Bristol-Myers Squibb Co, Meiji Holdings Co Ltd., Nestlé Health Science S.A., Ajinomoto Corporation, Mount Sinai Health System, BioMarin Pharmaceutical Inc, Gerber Products Company, Metagenics Inc., Vitaflo International, SHS International Limited, Merck $ Co Inc., Galen Medical Group, Applied Nutrition Corp., Primus Pharmaceuticals Inc., Reckitt Benckiser Group Plc, Ener-G Foods Inc, Pristine Organics Pvt. Ltd., Cymbiotika LLC, BC Children's Hospital, NutriScience Innovations LLC, Solace Nutrition LLC

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/medical-foods-for-inborn-errors-of-metabolism-global-market-report

Top Trend - Breakthrough Innovation In Medical Food For Inborn Errors In Metabolism Market
Product innovation has emerged as a key trend gaining popularity in medical food for inborn errors in the metabolism market. Major companies operating in medical food for inborn errors in the metabolism market are concentrating on creating innovative products to strengthen their position in the market. For instance, in December 2021, SFI Health, a Switzerland-based natural healthcare company introduced EQUAZEN PRO, a specially formulated medical food for the dietary treatment of a disease or condition with specific nutritional requirements for omega fatty acid levels. EQUAZEN PRO promotes healthy fatty acid metabolism and helps to restore omega-heavy acid levels. EQUAZEN PRO is scientifically proven to improve brain health for children and adolescents with ADHD and associated neurodiverse diseases to offer nutritional assistance. It contains sustainably obtained fish oils and evening primrose oil, and the capsule shell composition guarantees gastro resistance, delaying the transfer of fish oil from the stomach to the intestine and avoiding probable fishy flavor or reflux.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Medical Foods For Inborn Errors Of Metabolism Market Characteristics
3. Medical Foods For Inborn Errors Of Metabolism Market Trends And Strategies
4. Medical Foods For Inborn Errors Of Metabolism Market - Macro Economic Scenario
5. Medical Foods For Inborn Errors Of Metabolism Market Size And Growth
…..
27. Medical Foods For Inborn Errors Of Metabolism Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.